Securities code: 300357 securities abbreviation: Zhejiang Wolwo Bio-Pharmaceutical Co.Ltd(300357) Announcement No.: 2022-004
Zhejiang Wolwo Bio-Pharmaceutical Co.Ltd(300357)
Announcement on the progress of using idle self owned funds to purchase financial products
The company and all members of the board of directors guarantee that the content of information disclosure is true, accurate and complete without falsehood
False records, misleading statements or material omissions.
Zhejiang Wolwo Bio-Pharmaceutical Co.Ltd(300357) (hereinafter referred to as "the company") was called on April 27, 2021
The 11th meeting of the 4th board of directors was held, and the 2020 annual general meeting of shareholders was held on May 19, 2021 for deliberation
Passed the proposal on using idle self owned funds to purchase financial products and agreed with the company and its holding subsidiaries
When using idle self owned funds with a limit of no more than 800 million yuan (including the principal) to purchase low-risk financial products, the principal amount
Within the time limit, the funds can be used on a rolling basis, and the investment period of a single financial product shall not exceed 12 months. For details, see
Published on cninfo.com.cn on April 28, 2021 Relevant announcements. Now related
The progress announcement is as follows:
1、 Basic information of financial products
Serial amount product calculation annualized number signing bank product name (10000 yuan) product type value date maturity rate of return (%)
China Citic Bank Corporation Limited(601998) win win stable cycle 182 days (Zun 5000.00 non breakeven floating, December 2021, 3.55% 1 Deqing sub branch in 2022) revenue based financial management June 2
Dechang fixed term bank 2021-2028 {328.6012} 2. 186 days of sub branch structured deposits (linked to 3000.00 structured deposits on July 31 and 4% linked exchange rate on July 5)
Bank of communications Deqing Bank Of Communications Co.Ltd(601328) Yuntong wealth regular December 2021 1 1.85% - 3.85% 2022 3. 186 days of sub branch structured deposits (linked to 3000.00 structured deposits on July 31 and 4% linked exchange rate on July 5)
Bocom wealth management enjoys stable cash profit adding fixed income -
Bank of communications Deqing, non breakeven, January 2022
4 sub branch (legal person version for a long time only) produces 400.00 floating income type on the 24th of month (note) 2.72% product D financial management
Non breakeven floating 2022 1 2022
5 Industrial Bank Co.Ltd(601166) Societe Generale financial snowball stable quarterly income and net value April 29 3.84% Deqing sub branch Jifeng 5000.00 daily
Bocom wealth management enjoys stable cash profit adding fixed income -
Bank of communications Deqing, non breakeven, January 2022
6 sub branch (corporate version for a long time only) produces 800.00 floating income type. On the 30th of the month (note) 2.71% product D financial management
Note: the investment period of this financial product will not exceed 12 months (inclusive).
2、 Approval procedure
The company held the 11th meeting of the 4th board of directors on April 27, 2021 and the 2020 annual general meeting of shareholders on May 19, 2021. The proposal on using idle self owned funds to purchase financial products was reviewed and approved, and the company and its holding subsidiaries agreed to use idle self owned funds with a limit of no more than 800 million yuan (including this amount) to purchase low-risk financial products, which are within this limit, The funds can be used on a rolling basis, and the investment period of a single financial product shall not exceed 12 months. The independent directors of the company expressed their independent opinions on this matter.
As of the disclosure date of this announcement, the outstanding balance of the company and its holding subsidiaries' rolling use of idle self owned funds to purchase financial products in the first 12 months was RMB 334 million, which did not exceed the amount authorized by the general meeting of shareholders.
3、 Main investment risk disclosure and risk control measures
1. Investment risk
Investment risk mainly includes income risk, policy risk, liquidity risk, early termination risk, information transmission risk and other common risks of financial products.
2. Risk control measures
(1) The relevant financial personnel of the company and its holding subsidiaries will timely analyze and track the progress. If the assessment finds that there are risk factors that may affect the safety of funds, they will take corresponding measures in time to control the investment risk. (2) The company will strictly abide by the principle of prudent investment, choose low-risk financial investment varieties and act according to its ability. When selecting investment opportunities and investment varieties, the finance department is responsible for reviewing the product investment documents of financial institutions, consulting finance and securities professionals when necessary, and putting forward investment reference opinions.
(3) The internal audit department of the company is responsible for auditing and supervising the use and custody of investment and financial management funds, conducting regular comprehensive inspection on all investment projects of financial products, and reasonably predicting the possible gains and losses of various investments according to the principle of prudence.
(4) Independent directors and the board of supervisors have the right to supervise and inspect the use of funds, and can hire professional institutions to audit when necessary.
4、 Impact on the company
1. The company and its holding subsidiaries adhere to the principles of standardized operation, risk prevention, prudent investment and value preservation and appreciation. The use of idle self owned funds to purchase low-risk financial products is implemented on the premise of ensuring the daily operation and capital safety of the company, which does not affect the normal capital turnover needs of the company and its holding subsidiaries, It will not affect the normal development of the main business of the company and its holding subsidiaries.
2. Appropriate investment in low-risk financial products can improve the efficiency of capital use, obtain a certain return on investment, further improve the overall performance level of the company and fully protect the interests of shareholders.
5、 Description of other matters
The company has no relationship with China Citic Bank Corporation Limited(601998) , Bank Of Communications Co.Ltd(601328) , Industrial Bank Co.Ltd(601166) .
6、 Documents for future reference
Product agreement, risk disclosure and bank receipt of China Citic Bank Corporation Limited(601998) , Bank Of Communications Co.Ltd(601328) , Industrial Bank Co.Ltd(601166) .
It is hereby announced.
Zhejiang Wolwo Bio-Pharmaceutical Co.Ltd(300357) board of directors February 8, 2022
